Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

NCT01933061 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Strategic decision not to proceed with the opening of this study. There are no concerns over the safety or quality of the investigational products involved.

Conditions

Interventions

Sponsor

Celgene Corporation